Search Results - "Langevin, T."

Primary Episcleral Melanoma Consistent with Uveal Melanoma Mutations Treated by Excision and Gamma Knife Stereotactic Radiosurgery by Langevin, Spencer T., Chang, Eileen, Wang, Tony J.C., Deutsch, Israel, Otten, Marc, Marr, Brian P.

“…Ocular melanocytosis has traditionally been associated with increased risk of developing uveal melanoma; however, rarely primary episcleral melanoma has been…”
Get full text

Fellow-Eye Retinal Detachment Risk as Stratified by Hyaloid Status on OCT by Wallsh, Josh O., Langevin, Spencer T., Kumar, Aman, Huz, Jonathan, Falk, Naomi S., Bhatnagar, Pawan

“…To evaluate the risk of a rhegmatogenous retinal detachment (RRD) in the fellow eye using posterior hyaloid status as determined by OCT at the time of initial…”
Get full text

Adolescent Boy With Choroidal Mass by Langevin, Spencer T, Marr, Brian P

Get more information

Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease by Vergallo, Andrea, Mégret, Lucile, Lista, Simone, Cavedo, Enrica, Zetterberg, Henrik, Blennow, Kaj, Vanmechelen, Eugeen, De Vos, Ann, Habert, Marie-Odile, Potier, Marie-Claude, Dubois, Bruno, Neri, Christian, Hampel, Harald, Bakardjian, H., Benali, H., Bertin, H., Bonheur, J., Boukadida, L., Boukerrou, N., Cavedo, E., Chiesa, P., Colliot, O., Dubois, B., Dubois, M., Epelbaum, S., Gagliardi, G., Genthon, R., Habert, M.O., Hampel, H., Houot, M., Kas, A., Lamari, F., Levy, M., Metzinger, C., Mochel, F., Nyasse, F., Poisson, C., Revillon, M., Santos, A., Andrade, K.S., Sole, M., Surtee, M., de Schotten M, Thiebaud, Vergallo, A., Babiloni, Claudio, Baldacci, Filippo, Benda, Norbert, Black, Keith L., Bokde, Arun L.W., Bonuccelli, Ubaldo, Broich, Karl, Cacciola, Francesco, Castrillo, Juan, Cavedo, Enrica, Chiesa, Patrizia A., Corvol, Jean-Christophe, Cuello, Augusto Claudio, Cummings, Jeffrey L., Depypere, Herman, Dubois, Bruno, Duggento, Andrea, Escott-Price, Valentina, Federoff, Howard, Ferretti, Maria Teresa, Fiandaca, Massimo, Frank, Richard A., Garaci, Francesco, Geerts, Hugo, Giorgi, Filippo S., Graziani, Manuela, Haberkamp, Marion, Habert, Marie-Odile, Hampel, Harald, Herholz, Karl, Karran, Eric, Kim, Seung H., Koronyo, Yosef, Koronyo-Hamaoui, Maya, Lamari, Foudil, Langevin, Todd, Lehéricy, Stéphane, Lista, Simone, Lorenceau, Jean, Mango, Dalila, Neri, Christian, Nisticò, Robert, O'Bryant, Sid E., Perry, George, Ritchie, Craig, Rossi, Simone, Saidi, Amira, Schneider, Lon S., Sporns, Olaf, Toschi, Nicola, Verdooner, Steven R., Vergallo, Andrea, Villain, Nicolas, Welikovitch, Lindsay A., Woodcock, Janet, Younesi, Erfan

“…Blood-based biomarkers of pathophysiological brain amyloid β (Aβ) accumulation, particularly for preclinical target and large-scale interventions, are…”
Get full text

High-dose intensity systemic therapy of metastatic bladder cancer by Hrushesky, W J, Roemeling, R V, Wood, P A, Langevin, T R, Lange, P, Farley, E

“…Forty-three consecutively diagnosed patients with widely metastatic transitional cell carcinoma of the bladder (TCCB) were treated with a high-dose intensity,…”
Get more information

Circadian rhythm and seasonal dependence in the toxicological response of mice to epirubicin by Mormont, M C, von Roemeling, R, Sothern, R B, Berestka, J S, Langevin, T R, Wick, M, Hrushesky, W J

“…Compared to doxorubicin, equimolar epirubicin toxicity is reduced by about 50% by the epimerization of a hydrogen and hydroxyl group at the 4' position of the…”
Get full text

Chemotherapy via implanted infusion pump: new perspectives for delivery of long-term continuous treatment by von Roemeling, R, MacDonald, M, Langevin, T, Buchwald, H, Hrushesky, W J

Get more information

High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer by Hrushesky, W J, Roemeling, R V, Wood, P A, Langevin, T R, Lange, P, Fraley, E

“…Thirteen patients with transitional cell carcinoma of the bladder received monthly circadian-timed doxorubicin and cisplatin chemotherapy immediately after…”
Get more information

Methylene blue protects intestinal mucosa from free radical-mediated sublethal radiation damage by Hrushesky, W J, Berestka, J S, von Roemeling, R, Olshefski, R, Langevin, T R, Potish, R A, Delaney, J P, Ellefson, M, Schwartz, S

“…Susceptibility of the intestine to radiation damage is a primary reason for the failure of external beam radiation to cure intra-abdominal cancer. High-dose…”
Get more information

The role of implanted systems in the control of temporal drug delivery by Langevin, T

“…It is clear from the abundance of research and published data, temporal drug delivery has utility across all medical disciplines. Though some applications are…”
Get more information

Circadian dynamics of tumor necrosis factor α (Cachectin) lethality by HRUSHESKY, W. J. M, LANGEVIN, T, KIM, Y. J, WOOD, P. A

“…Recombinant human tumor necrosis factor-alpha (TNF-alpha) has demonstrable antitumor activity in transplantable murine tumor models and patients with cancer…”
Get full text

Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration by Levi, F A, Hrushesky, W J, Halberg, F, Langevin, T R, Haus, E, Kennedy, B J

“…Three hundred and forty-one female F344 (Fischer) rats were kept in light for 8 hr alternating with darkness for 16 hr; some were observed for survival for 21…”
Get more information

Primary Episcleral Melanoma Consistent with Uveal Melanoma Mutations Treated by Excision and Gamma Knife Stereotactic Radiosurgery by Langevin, Spencer T, Chang, Eileen, Wang, Tony J C, Deutsch, Israel, Otten, Marc, Marr, Brian P

Get full text

Automatic anticancer chronotherapy using implanted programmable pumps: An attempt to improve therapeutic index by Roemeling, R. V., Langevin, T. R., Berestka, J., Rabatin, J. T., Buchwald, H., Kennedy, B. J., Hrushesky, W. J. M.

Get full text

Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats by Rosenberg, C A, Hrushesky, W J, Langevin, T, Kennedy, B J

“…The relative efficacy of hormonal, chemical, or combined therapy was investigated in a prostate cancer animal model. 96 Copenhagen-Fischer hybrid rats were…”
Get more information

Cisplatin chronotherapy and disulfiram rescue reduce toxicity without interfering with anticancer activity: animal findings and preliminary clinical experiences by Roemeling, R V, Olshefski, R, Langevin, T, Berestka, J, Reusch, J J, Reusch, J E, Lakatua, D, Wick, M R, Hrushesky, W J

“…Cisplatin-induced mortality and nephrotoxicity are each predictably worse when the drug is given at certain points within the circadian schedule. Oral…”
Get more information